Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 43.46M P/E - EPS this Y - Ern Qtrly Grth -
Income -5.77M Forward P/E -51.00 EPS next Y - 50D Avg Chg 6.00%
Sales 17.47M PEG - EPS past 5Y 53.90% 200D Avg Chg -8.00%
Dividend N/A Price/Book 1.54 EPS next 5Y - 52W High Chg -42.00%
Recommedations 2.00 Quick Ratio 0.76 Shares Outstanding 7.82M 52W Low Chg 32.00%
Insider Own 27.18% ROA -7.36% Shares Float 5.64M Beta 0.61
Inst Own 13.30% ROE -20.86% Shares Shorted/Prior 5.10K/6.12K Price 5.61
Gross Margin 25.16% Profit Margin -33.05% Avg. Volume 11,946 Target Price -
Oper. Margin -9.35% Earnings Date Aug 8 Volume 13,146 Change 3.89%
About ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

ImmuCell Corporation News
05/14/24 ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
05/08/24 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024
04/09/24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
02/29/24 ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript
02/27/24 ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
02/16/24 ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
01/08/24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
11/15/23 ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript
11/13/23 ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
11/07/23 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
10/05/23 ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
08/29/23 ImmuCell Announces Submission of CMC Technical Section to the FDA
08/11/23 Q2 2023 ImmuCell Corp Earnings Call
08/10/23 ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
08/07/23 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
07/11/23 ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
06/28/23 ImmuCell Announces Change in Timing of Anticipated FDA Submission
06/21/23 ImmuCell Appoints Bryan K. Gathagan to Board of Directors
06/15/23 ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility
ICCC Chatroom

User Image winston319 Posted - 1 day ago

$ICCC maybe they can launch retain by the first quarter of next year let’s hope

User Image SIGNORAMOUS Posted - 2 days ago

$ICCC On June 21, ICCC named Bryan Gaffigan to the Board of Dirctors. “Bryan’s depth of experience in the animal health industry and his financial skills will be a great asset to ImmuCell,” commented Michael F. Brigham, President and CEO of ImmuCell. “We all look forward to working with him and adding his perspective to our business operations and strategies.” On June 28, ICCC announced a change in timing to the anticipated FDA submission. I thought at the time, and hoped, they were adding acumen pertinent to getting the submission through, acumen the company seemed to have lacked in the past. I take the news that has been released this afternoon about ReTain to be a positive indicator. I'm surprised that there has been no after-hours movement in either direction. Even after the call tomorrow, I can only hope that the price action will be positive on the stock. Thoughts?

User Image TommyTwenty Posted - 2 days ago

$ICCC

User Image Glopolon Posted - 2 days ago

$ICCC "However, the FDA has indicated that this re-submission potentially could be handled through a shortened review period because the open items are not complex"

User Image TommyTwenty Posted - 2 days ago

$ICCC The FDA has delayed the approval of ImmuCell's Re-Tain® product due to pending inspectional observations at their contract manufacturer

User Image Stock_Titan Posted - 2 days ago

$ICCC ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 https://www.stocktitan.net/news/ICCC/immu-cell-announces-unaudited-financial-results-for-the-quarter-67zk4g59v612.html

User Image TommyTwenty Posted - 1 week ago

$ICCC CC was supposed to be tomorrow but they’re pushing it back 5 days 🤔

User Image Stock_Titan Posted - 1 week ago

$ICCC ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 https://www.stocktitan.net/news/ICCC/immu-cell-to-announce-unaudited-financial-results-for-the-quarter-nsuytagnq972.html

User Image raventhemonkey Posted - 1 week ago

$ICCC Ok, it's May. If Retain is approved by the FDA any guesses on the stock price?

User Image TommyTwenty Posted - 1 month ago

$ICCC looks like we’re in dilution as the outstanding shares have been increasing. Prospectus says they’ve been selling the shares for 5.16. I’ve increased my position about 10%.

User Image stockregion Posted - 1 month ago

ImmuCell's Record-Breaking Q1 2024 Sales: A Sign of Strong Growth and Future Potential. ImmuCell Corporation (Nasdaq: ICCC), a key player in the animal health industry, has recently announced its preliminary, unaudited sales results for the first quarter of 2024, and the figures are nothing short of impressive. With a staggering 111% increase in sales compared to the same period in 2023, and a 42% increase from the last quarter of 2023, ImmuCell has undoubtedly set a new benchmark for itself and the industry. The company's total sales for the three-month period ending March 31, 2024, reached $7.3 million, marking an all-time quarterly sales record. This performance exceeds their next best quarter by 21%, or $1.3 million, underscoring the company's robust growth trajectory. $ICCC https://stockregion.app/p/animal-health-company-reports-preliminary

User Image stockregion Posted - 1 month ago

Pre-market Watch: $UCAR $ICCC $PFMT $INAB JOIN US 👉 https://stockregion.net

User Image winston319 Posted - 1 month ago

$ICCC looks like Mikeael is riding the ship so that means they should’ve turned. The small profit is quarter two so very good.

User Image Glopolon Posted - 1 month ago

$ICCC “We expect a response from the FDA to our third submission of the CMC Technical Section no later than May 2024.”

User Image Glopolon Posted - 1 month ago

$ICCC number of shares of the registrant’s common stock outstanding as of March 8, 2024 was 7,750,864.

User Image Glopolon Posted - 1 month ago

$ICCC “The $7.3 million in total product sales achieved during the first quarter of 2024 is an all-time quarterly sales record for us,” commented Michael F. Brigham, President and CEO of ImmuCell. “This high mark in sales exceeds our next best quarter of $6 million during the first quarter of 2022 by 21%, or $1.3 million.”

User Image TommyTwenty Posted - 1 month ago

$ICCC 7.3 million sales. Stocks almost 1/1 p/s ratio. No retain surprises. Great quarter.

User Image Stock_Titan Posted - 1 month ago

$ICCC ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 https://www.stocktitan.net/news/ICCC/immu-cell-announces-preliminary-unaudited-sales-results-for-q1-0g2jb4g811qk.html

User Image DonCorleone77 Posted - 1 month ago

$ICCC Immucell files $20M mixed securities shelf

User Image winston319 Posted - 03/19/24

$ICCC come on two more months to go

User Image TommyTwenty Posted - 2 months ago

$ICCC broke above the 200 day moving average about 2 months ago and has been bouncing off it ever since.

User Image SIGNORAMOUS Posted - 2 months ago

$ICCC Down over 15% over the weekend. Normally I shrug off movement on this stock and I'm trying to do that again now. I don't see any news. Sheesh

User Image TommyTwenty Posted - 02/28/24

$ICCC https://bnnbreaking.com/finance-nav/immucell-navigates-production-hurdles-and-fda-delays-eyes-growth-in-2024

User Image winston319 Posted - 02/28/24

$ICCC anybody gets to listen to the conference call there’s anything good hosted up I can’t get access to wait around this evening due to my work schedule

User Image winston319 Posted - 02/27/24

$ICCC well nothing that we don’t know already I didn’t get to read the whole thing just as far as the income goes and the earning share loss about $1 million is quarter hopefully they start turning this around here. Going forward in 2024 Start making some money.

User Image Stock_Titan Posted - 02/27/24

$ICCC ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 https://www.stocktitan.net/news/ICCC/immu-cell-announces-unaudited-financial-results-for-the-quarter-and-6js1sf2g9ifi.html

User Image Ninja_Tradez Posted - 3 months ago

📢 $ICCC - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 https://newsfilter.io/a/311332efc0985db6b7e8e10da0570401

User Image Stock_Titan Posted - 3 months ago

$ICCC ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 https://www.stocktitan.net/news/ICCC/immu-cell-to-announce-unaudited-financial-results-for-the-quarter-jguqhqhu5q9m.html

User Image SIGNORAMOUS Posted - 3 months ago

$ICCC It seems that we are going down right now on good news today In addition to reporting a strong quarter, there was this statement about Re-Tain. “In addition, we continue to work to achieve FDA approval to commercialize Re-Tain®,” Mr. Brigham concluded. “We expect a response from the FDA to our third submission of the CMC Technical Section no later than May 2024.” I take that to mean that there are no FDA procedural reasons for delay and that their application will be considered on its merit

User Image winston319 Posted - 01/19/24

$ICCC state to Ashton Kusher

Analyst Ratings
Aegis Capital Buy Jul 13, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Cunningham David Director Director Jun 13 Buy 8.0000 1,000 8,000 16,000 06/14/22